|
1
|
Quatrano NA and Loechner KJ: Dermatologic
manifestations of endocrine disorders. Curr Opin Pediatr.
24:487–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Phiske MM: An approach to acanthosis
nigricans. Indian Dermatol Online J. 5:239–249. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gómez-Flores M, González-Saldivar G,
Santos-Santos O, Álvarez-Villalobos N, Rodríguez-Gutiérrez R,
Tellez-Hinojosa C and González-González J: Implications of a
clinically ignored site of acanthosis nigricans: The knuckles. Exp
Clin Endocrinol Diabetes. 123:27–33. 2015.PubMed/NCBI
|
|
4
|
Schnopp C and Baumstark J: Images in
clinical medicine. Oral acanthosis nigricans. N Engl J Med.
357:e102007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Judge MR, McLean WH and Munro C: Disorders
of keratinization. Rook's Textbook of Dermatology. 8th. Burns T,
Breathnach S, Cox N and Griffiths C: Blackwell Publishing; Oxford:
pp. 119–121. 2010
|
|
6
|
Pollitzer S and Janovsky V: Acanthosis
nigricans. In: International Atlas of Rare Skin Diseases. IV.
Morris M, Unna PG, Leloir HC and Duhring L: Leopold Voss, Hamburg:
1891
|
|
7
|
Kutlubay Z, Engin B, Bairamov O and Tüzün
Y: Acanthosis nigricans: A fold (intertriginous) dermatosis. Clin
Dermatol. 33:466–470. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gossman WG and Bhimji SS: Acanthosis
nigricans. StatPearls [Internet]. StatPearls Publishing; Treasure
Island, FL: 2018
|
|
9
|
Hud JA Jr, Cohen JB, Wagner JM and Cruz PD
Jr: Prevalence and significance of acanthosis nigricans in an adult
obese population. Arch Dermatol. 128:941–944. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hernández-Pérez E: On the classification
of acanthosis nigricans. Int J Dermatol. 23:605–606. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Curth HO: Classification of acanthosis
nigricans. Int J Dermatol. 15:592–593. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burke JP, Hale DE, Hazuda HP and Stern MP:
A quantitative scale of acanthosis nigricans. Diabetes Care.
22:1655–1659. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sinha S and Schwartz RA: Juvenile
acanthosis nigricans. J Am Acad Dermatol. 57:502–508. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
González-Saldivar G, Rodríguez-Gutiérrez
R, Ocampo-Candiani J, González-González JG and Gómez-Flores M: Skin
manifestations of insulin resistance: From a biochemical stance to
a clinical diagnosis and management. Dermatol Ther (Heidelb).
7:37–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khokhar A, Chin V, Perez-Colon S, Farook
T, Bansal S, Kochummen E and Umpaichitra V: Differences between
metabolically gealthy vs. unhealthy obese children and adolescents.
J Natl Med Assoc. 109:203–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Panda S, Das A, Lahiri K, Chatterjee M,
Padhi T, Rathi S, Dhar S and Sarma N: Facial acanthosis nigricans:
A morphological marker of metabolic syndrome. Indian J Dermatol.
62:591–597. 2017.PubMed/NCBI
|
|
17
|
Jeong KH, Oh SJ, Chon S and Lee MH:
Generalized acanthosis nigricans related to type B insulin
resistance syndrome: A case report. Cutis. 86:299–302.
2010.PubMed/NCBI
|
|
18
|
Jeong JS, Lee JY and Yoon TY: Unilateral
nevoid acanthosis nigricans with a submammary location. Ann
Dermatol. 23:95–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Innaurato S, Brierley GV, Grasso V,
Massimi A, Gaudino R, Sileno S, Bernardini S, Semple R and Barbetti
F: Severe insulin resistance in disguise: A familial case of
reactive hypoglycemia associated with a novel heterozygous INSR
mutation. Pediatr Diabetes. 19:670–674. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HN, Fesseha B, Anzaldi L, Tsao A,
Galiatsatos P and Sidhaye A: Antibody-mediated extreme insulin
resistance: A Report of three cases. Am J Med. 131:102–106. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kondo Y, Umegaki N, Terao M, Murota H,
Kimura T and Katayama I: A case of generalized acanthosis nigricans
with positive lupus erythematosus-related autoantibodies and
antimicrosomal antibody: Autoimmune acanthosis nigricans? Case Rep
Dermatol. 4:85–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miquel J, Hadj-Rabia S, Boddaert N,
Lascelles K and Bahi-Buisson N: Atypical presentation of
neuropsychiatric lupus with acanthosis nigricans. Pediatr Neurol.
47:291–294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sturner RA, Denning S and Marchase P:
Acanthosis nigricans and autoimmune reactivity. JAMA. 246:763–765.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schwartz RA: Acanthosis nigricans. J Am
Acad Dermatol. 31:1–22. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hartman R, Defelice T, Tzu J, Meehan S and
Sanchez M: Acanthosis nigricans in the setting of niacin therapy.
Dermatol Online J. 17:112011.PubMed/NCBI
|
|
26
|
Erickson L, Lipschutz DE, Wrigley W and
Kearse WO: A peculiar cutaneous reaction to repeated injections of
insulin. JAMA. 209:934–935. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sawatkar GU, Dogra S, Bhadada SK and
Kanwar AJ: Acanthosis nigricans - an uncommon cutaneous adverse
effect of a common medication: Report of two cases. Indian J
Dermatol Venereol Leprol. 79:5532013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bishnoi A and Parsad D: Velvety
hyperpigmentation on hands and feet of a young girl: Acral
acanthosis nigricans. J Cutan Med Surg. 22:3232018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kura MM and Sanghavi SA: Acral acanthosis
nigricans in a case of scleroderma. Indian J Dermatol. 60:4232015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anand V, Das A, Kumar P, Kumar R and
Hassan S: Acral acanthosis nigricans (acral acanthotic anomaly).
Indian Dermatol Online J. 5 (Suppl 2):S140–S141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cama A, Sierra ML, Kadowaki T, Kadowaki H,
Quon MJ, Rüdiger HW, Dreyer M and Taylor SI: Two mutant alleles of
the insulin receptor gene in a family with a genetic form of
insulin resistance: A 10 base pair deletion in exon 1 and a
mutation substituting serine for asparagine-462. Hum Genet.
95:174–182. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Puri N: A study of pathogenesis of
acanthosis nigricans and its clinical implications. Indian J
Dermatol. 56:678–683. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Degirmentepe EN, Gungor S, Kocaturk E,
Kiziltac U, Adas M, Ozekinci S and Khachemoune A: Dermatologic
manifestations of acromegaly: A case in point and a focused review.
Dermatol Online J. 23:232017.
|
|
34
|
Yosipovitch G, DeVore A and Dawn A:
Obesity and the skin: Skin physiology and skin manifestations of
obesity. J Am Acad Dermatol. 56:901–916; quiz 917–920. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jabbour SA: Cutaneous manifestations of
endocrine disorders: A guide for dermatologists. Am J Clin
Dermatol. 4:315–331. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schmidt TH, Khanijow K, Cedars MI,
Huddleston H, Pasch L, Wang ET, Lee J, Zane LT and Shinkai K:
Cutaneous findings and systemic associations in women with
polycystic ovary syndrome. JAMA Dermatol. 152:391–398. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stratakis CA: Skin manifestations of
Cushing's syndrome. Rev Endocr Metab Disord. 17:283–286. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ober KP: Acanthosis nigricans and insulin
resistance associated with hypothyroidism. Arch Dermatol.
121:229–231. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Scheinfeld NS: Obesity and dermatology.
Clin Dermatol. 22:303–309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gheorghisan-Galateanu AA, Terzea D, Valea
A and Carsote M: Menopausal androgen excess - associated
cardio-metabolic risk: Clues for ovarian Leydig cell tumour (case
report and mini-review of literature). Acta Endocrinol (Copenh).
13:356–363. 2017.
|
|
41
|
Moller DE and Flier JS: Insulin resistance
- mechanisms, syndromes, and implications. N Engl J Med.
325:938–948. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Barbato MT, Criado PR, Silva AK, Averbeck
E, Guerine MB and Sá NB: Association of acanthosis nigricans and
skin tags with insulin resistance. An Bras Dermatol. 87:97–104.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Assunção SN, Boa Sorte NC, Alves CA,
Mendes PS, Alves CR and Silva LR: Glucose alteration and insulin
resistance in asymptomatic obese children and adolescents. J
Pediatr (Rio J). 94:268–272. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rodríguez-Gutiérrez R, Salcido-Montenegro
A and González-González JG: Early clinical expressions of insulin
resistance: The real enemy to look for. Diabetes Ther. 9:435–438.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guevara-Gutiérrez E, Tlacuilo-Parra A,
Gutiérrez-Fajardo P, Sánchez-Tenorio T, Barba-Gómez F and
Miranda-Díaz A: A study of the association of acanthosis nigricans
with subclinical atherosclerosis. Indian J Dermatol Venereol
Leprol. 83:190–194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Krawczyk M, Mykała-Cieśla J and
Kołodziej-Jaskuła A: Acanthosis nigricans as a paraneoplastic
syndrome. Case reports and review of literature. Pol Arch Med Wewn.
119:180–183. 2009.PubMed/NCBI
|
|
47
|
Ramirez-Amador V, Esquivel-Pedraza L,
Caballero-Mendoza E, Berumen-Campos J, Orozco-Topete R and
Angeles-Angeles A: Oral manifestations as a hallmark of malignant
acanthosis nigricans. J Oral Pathol Med. 28:278–281. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Deen J, Moloney T and Burdon-Jones D:
Severe, malignant acanthosis nigricans associated with
adenocarcinoma of the endometrium in a young obese female. Case Rep
Dermatol. 9:30–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Moreno-Artero E, Querol E, Ivars M, Sola
I, Pío R and España A: Assessment of EGF receptor ligand expression
in gastric carcinoma and in lesional skin of paraneoplastic
acanthosis nigricans: A case report. J Eur Acad Dermatol Venereol.
31:e301–e302. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tammaro A, Giulianelli V, Parisella F and
Persechino S: Bilaterally mammary acanthosis nigricans as
paraneoplastic manifestation of prostate adenocarcinoma. G Ital
Dermatol Venereol. 151:578–579. 2016.PubMed/NCBI
|
|
51
|
Karakas Y, Esin E, Lacin S, Ceyhan K,
Heper AO and Yalcin S: A case of acanthosis nigricans as a
paraneoplastic syndrome with squamous cell lung cancer. OncoTargets
Ther. 9:4815–4820. 2016. View Article : Google Scholar
|
|
52
|
Ferraz de Campos FP, Narvaez MR, Reis PV,
Gomes AC, Paraskevopoulos DK, Santana F and Fugita OE: Acanthosis
nigricans associated with clear-cell renal cell carcinoma. Autops
Case Rep. 6:33–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vilas-Sueiro A, Suárez-Amor Ó, Monteagudo
B and de Las Heras C: Malignant acanthosis nigricans, florid
cutaneous and mucosal papillomatosis, and tripe palms in a man with
gastric adenocarcinoma. Actas Dermosifiliogr. 106:438–439. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ni QF, Liu GQ, Pu LY, Kong LL and Kong LB:
Dermatomyositis associated with gallbladder carcinoma: A case
report. World J Hepatol. 5:230–233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Olek-Hrab K, Silny W, Zaba R,
Osmola-Mańkowska A, Mackiewicz-Wysocka M and Dańczak-Pazdrowska A:
Co-occurrence of acanthosis nigricans and bladder adenocarcinoma -
case report. Contemp Oncol (Pozn). 17:327–330. 2013.PubMed/NCBI
|
|
56
|
Solomon I, Voiculescu VM, Caruntu C, Lupu
M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C,
et al: Neuroendocrine factors and head and neck squamous cell
carcinoma: An affair to remember. Dis Markers.
2018:97878312018.doi: 10.1155/2018/9787831. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Voiculescu VM, Caruntu C, Solomon I, Lupu
M, Ilie MA, Boda D, Constantin C and Neagu M: Squamous cell
carcinoma - Biomarkers and potential therapeutic targets. Human
Skin Cancers, Potential Biomarkers and Therapeutic Targets.
Blumberg M: IntechOpen; London: pp. 135–159. 2018
|
|
58
|
Tanase CP, Neagu M and Albulescu R: Key
signaling molecules in pituitary tumors. Expert Rev Mol Diagn.
9:859–877. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Moore RL and Devere TS: Epidermal
manifestations of internal malignancy. Dermatol Clin. 26:17–29.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mascitti M, Santarelli A, Albanese A,
Campisi G and Muzio LL: Paraneoplastic acanthosis nigricans
maligna. Ann Stomatol (Roma). 4 (Suppl 2):292013.
|
|
61
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LM, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, et al: Neuroendocrine factors: The missing link in non melanoma
skin cancer (Review). Oncol Rep. 38:1327–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Patra S, Chakraborty PP, Barman H and
Santra G: Acanthosis nigricans in insulinoma: before and after
successful surgical enucleation. BMJ Case Rep.
2016.bcr20162180032016.doi: 10.1136/bcr-2016-218003. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jyotsna VP, Raizada N, Chakraborty S and
Pal S: Acanthosis nigricans in insulinoma. Indian J Endocrinol
Metab. 18:7392014.PubMed/NCBI
|
|
64
|
Gudala M, Ahmed M, Conroy R and
Tonyushkina K: Insulinoma masquerading as a loss of consciousness
in a teenage girl: Case report and literature review. Int J Pediatr
Endocrinol. 2017:132017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Higgins SP, Freemark M and Prose NS:
Acanthosis nigricans: A practical approach to evaluation and
management. Dermatol Online J. 14:22008.PubMed/NCBI
|
|
66
|
Torley D, Bellus GA and Munro CS: Genes,
growth factors and acanthosis nigricans. Br J Dermatol.
147:1096–1101. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Rudman SM, Philpott MP, Thomas GA and
Kealey T: The role of IGF-I in human skin and its appendages:
Morphogen as well as mitogen? J Invest Dermatol. 109:770–777. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Napolitano M, Megna M and Monfrecola G:
Insulin resistance and skin diseases. Sci World J. 2015:4793542015.
View Article : Google Scholar
|
|
70
|
Blomberg M, Jeppesen EM, Skovby F and
Benfeldt E: FGFR3 mutations and the skin: Report of a patient with
a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and
hyperinsulinemia and review of the literature. Dermatology.
220:297–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Mir A, Wu T and Orlow SJ: Cutaneous
features of Crouzon syndrome with acanthosis nigricans. JAMA
Dermatol. 149:737–741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lane SW, Manoharan S and Mollee PN:
Palifermin-induced acanthosis nigricans. Intern Med J. 37:417–418.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhang Y, Zhu C, Wen X, Wang X, Li L,
Rampersad S, Lu L, Zhou D, Qian C, Cui R, et al: Laparoscopic
sleeve gastrectomy improves body composition and alleviates insulin
resistance in obesity related acanthosis nigricans. Lipids Health
Dis. 16:2092017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gheuca Solovastru L, Vata D, Statescu L,
Constantin MM and Andrese E: Skin cancer between myth and reality,
yet ethically constrained. Rev Rom Bioet. 12:47–52. 2014.
|
|
75
|
Giri D, Alsaffar H and Ramakrishnan R:
Acanthosis nigricans and its response to metformin. Pediatr
Dermatol. 34:e281–e282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Romo A and Benavides S: Treatment options
in insulin resistance obesity-related acanthosis nigricans. Ann
Pharmacother. 42:1090–1094. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bellot-Rojas P, Posadas-Sanchez R,
Caracas-Portilla N, Zamora-Gonzalez J, Cardoso-Saldaña G,
Jurado-Santacruz F and Posadas-Romero C: Comparison of metformin
versus rosiglitazone in patients with Acanthosis nigricans: A pilot
study. J Drugs Dermatol. 5:884–889. 2006.PubMed/NCBI
|
|
78
|
Sinha SK, Bhangoo A, Anhalt H, Maclaren N,
Marshall JD, Collin GB, Naggert JK and Ten S: Effect of metformin
and rosiglitazone in a prepubertal boy with Alström syndrome. J
Pediatr Endocrinol Metab. 20:1045–1052. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Hermanns-Lê T, Scheen A and Piérard GE:
Acanthosis nigricans associated with insulin resistance:
Pathophysiology and management. Am J Clin Dermatol. 5:199–203.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Kumar N, Kaul CL, Ishrath A and Dey CS:
Combination of metformin and thiazolidindiones restore insulin
signalling in insulin-resistant cultured myotubes. Life Sci.
74:1877–1888. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Elkind-Hirsch KE: Thiazolidinediones for
the therapeutic management of polycystic ovary syndrome: Impact on
metabolic and reproductive abnormalities. Treat Endocrinol.
5:171–187. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Valizadeh N, Tehrani MR, Amoli MM and
Bandarian F: Severe acanthosis nigricans in a 17 year-old female
with partial lipodystrophic syndrome. J Pediatr Endocrinol Metab.
21:1027–1028. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sun H, Wang X, Chen J, Gusdon AM, Song K,
Li L and Qu S: Melatonin treatment improves insulin resistance and
pigmentation in obese patients with acanthosis nigricans. Int J
Endocrinol. 2018:23047462018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gorisek B, Krajnc I, Rems D and Kuhelj J:
Malignant acanthosis nigricans and tripe palms in a patient with
endometrial adenocarcinoma - a case report and review of
literature. Gynecol Oncol. 65:539–542. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ghosh S, Roychowdhury B, Mukhopadhyay S
and Chowdhury S: Clearance of acanthosis nigricans associated with
insulinoma following surgical resection. QJM. 101:899–900. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Pfeifer SL, Wilson RM and Gawkrodger DJ:
Clearance of acanthosis nigricans associated with the HAIR-AN
syndrome after partial pancreatectomy: An 11-year follow-up.
Postgrad Med J. 75:421–422. 1999. View Article : Google Scholar : PubMed/NCBI
|
